EyeWorld China March 2018

/CTEJ ŭ ʃ EWAP ጇᇕ 57 ࣹė뻟ĆģĻŘΜΜŞୂ뻟ƔŶ̹ ů .KRK(NQY뺯 ƎĐ뻟ֶŀƑĻĩĜdz᥿ ذ ფ එԇȆŪĄѝɕĀĂˌœ뺯qĿ ņ뻟ƧưĆĸoѝɕ뻟pࡥռֶŀ Šਮ͠ĜǂƛΞħĄؐ઄݀ఆ뻟 ƍćϿĠĉńĄĕĭΞħ뻟r&T *QNNCPF ĸ뺯qȚĄ᥿ ذ ფඑԇĄ Ȥؐ઄݀ఆƑ˩ȒĀѝɕ׮Տ뺯r Ŵĸ뻟ƍćֶŀͥǘΞԺė᥿ ذ ფ එԇŘӍ ܭ ਐॸ ߔ Āȶđȡ뺯 ̦ǁ ߖ պ ܭ ਐ 6TWG 6GCT뻟 #NNGTICP뻟&WDNKP뻟+TGNCPF Ŗ ˦Ȍī࣪Ѥůǘϑ ړ ѝɕਮ͠Ā ؐ઄ŀŪ뺯ĕƞƋ̰К뻟ʌˌ뻟ӣ Ǘ ؤ ѳ҄ĩѿмŀƱ̸뻟ʙĿᒖ ǡ̦ǁ٣๥ĢƔ̙ɍƁၫ̦ǁ ߖ պ뻟ŀŪؐ઄ĀǨĈƁƞǂđŪ œ뺯Ȃħ̦ǁ ߖ պăĄƋ׷ģă Ą ۽ ˀȡ뻟ĕĄĂƞĥՏ뻟ћ̖뻟 ĻĩĻŘŠȺ̋ ܭ ਐƶޯৗǜĀ ܭ ਐ٣К뻟&T 5JGRRCTF ĸ뺯 ŖŶ뻟ƲĂċċɆਮ͠ĝ̀ đශઇɕ̝Ծĉ˴ɘDŽċȡ͔Ӈ ଦ뻟јǭҒʸŴĶԇŰĀ ܭ ਐƶ К뺯ѝɕĄĂƞĠȂٌඑԇ뻟κ݉ ࢅժʹۗ뻟ʙ˩̀đǭʿćǜĂ ċɕֶؘŀͱԥʾ̅ŦƀΏႊ뻟 ɘDŽĠ٣К ܭ ਐ뻟&T 5JGRRCTF ĸ뺯 '9#2 ݬ ఠᆪማ 1. Sheppard JD Jr, et al. Long-term supplementation with n-6 and n-3 PUFAs improves moderate-to-se- vere keratoconjunctivitis sicca: a randomized double-blind clinical trial. Cornea . 2013;32:1297–304. 2. Epitropoulos AT, et al. īĞĐƚ ŽĨ oral re-esterified omega-3 nu- tritional supplementation on dry eyes. Cornea. 2016;35:1185–91. 3. Jones L, et al. TFOS DEWS II Management and Therapy Report. Ocul Surf. 2017;15:575–628. 4. Deinema LA, et al. A random- ized, double-masked, placebo-con- trolled clinical trial of two forms of omega-3 supplements for treating dry eye disease. Ophthalmology. 2017;124:43–52. ৠ٧ͩ뻭&T &QYPKG Š #NEQP (QT V 9QT VJ뻟6GZCU 뻟#N NGTI CP뻟Ӎ %QQRGT8KUKQP .CMG (QTGUV뻟%CNKHQTPKC Ĉǁ࢖ϙॼ ȱͷ뺯&T *QNNCPF Š 2J[UKEK CP 4GEQOOGPFGF 0WVTKEG WVKECNU $NWG $GNN뻟2GPPU[N XCP K C Ĉǁ࢖ϙॼȱͷ뺯& T 5JGRRCTFŠ,QJPUQP ,QJP UQP 8KUKQP Ӎ 5EKGPEG$CUGF *GCNVJ Ĉǁ࢖ϙॼȱͷ뺯 ԓͷƶК Downie: ldownie@unimelb.edu.au Holland: eholland@holprovision.com Sheppard: jsheppard@vec2020.com